BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

Advanced Search

10 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of EBI-2511: A Highly Potent and Orally Active EZH2 Inhibitor for the Treatment of Non-Hodgkin's Lymphoma.EBI
Shanghai Hengrui Pharmaceutical
Tetrahydroisoquinoline compound, preparation method therefor, pharmaceutical composition containing same, and use thereofBDB
Shanghai Institute of Materia Medica
Inhibitors of Rho associated coiled-coil containing protein kinaseBDB
Kadmon
Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseBDB
Shy Therapeutics
N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitorsBDB
Kalvista Pharmaceuticals
Inhibiting agents for Bruton's tyrosine kinaseBDB
Biogen Ma
Mixed lineage kinase inhibitors for HIV/AIDS therapiesBDB
The University of Rochester
Guanidine substituted tetrahydroisoquinoline compounds as factor XIa inhibitorsBDB
Bristol-Myers Squibb
Spiro-amino-imidazo-fused heterocyclic compounds as beta-secretase modulators and methods of useBDB
Amgen
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetesBDB
Merck Sharpe & Dohme